Catalyst Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

President delivering his second official state of the Union Address. It will be his first in this new era of divided government. Democratic House Speaker nancy pelosi will sit over his shoulder after outmaneuvering him during the government shutdown. The speech comes at a critical time in his president is i with not only a divided congress, but another shutdown looming over the border wall issue. The mueller investigation, the investigation in the Southern District of new york. It is a long list. That of course the focus this week in congress and elsewhere. Administration officials have been p...

Im christine romans. It is 4 00 a. M. In the east. And tonight President Trump delivers his second official state of the Union Address, his first in this new era of divided government. Democratic House Speaker nancy pelosi will sit over his shoulder, an optic i think that is just about something to watch. Something to watch. After outmaneuvering him during the Government Shutdown of course, this speech at a critical time in his president presidency. The theme tonight, choosing greatness. Ident presidency. The theme tonight, choosing greatness. This president is going to call for an end to the ...

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) insider Carmen Jeffrey Del sold 7,541 shares of the company’s stock in a transaction on Friday, June 7th. The stock was sold at an average price of $16.07, for a total transaction of $121,183.87. Following the completion of the sale, the insider now owns 18,427 shares of […]

Catalyst Pharmaceuticals (NASDAQ:CPRX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Friday. Several other analysts also recently commented on CPRX. Oppenheimer reaffirmed an “outperform” rating and set a $29.00 target price on shares of Catalyst Pharmaceuticals in a […]

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, May 28, 2024 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on June 18, 2024, at 10:00 CEST at Haus der Wirtschaft, Hardstrasse 1, 4133 Pratteln, Switzerland. The invitation to the AGM with agenda items and explanations will be sent to registered shareholders by mail and can be viewed on Santhera’s website at https://www.santhera.com/share-bondholder-me